329 related articles for article (PubMed ID: 25664866)
21. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012.
Miller JE; Korn D; Ross JS
BMJ Open; 2015 Nov; 5(11):e009758. PubMed ID: 26563214
[TBL] [Abstract][Full Text] [Related]
22. Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis.
Wallach JD; Egilman AC; Dhruva SS; McCarthy ME; Miller JE; Woloshin S; Schwartz LM; Ross JS
BMJ; 2018 May; 361():k2031. PubMed ID: 29794072
[TBL] [Abstract][Full Text] [Related]
23. Safety and transparency of pediatric drug trials.
Benjamin DK; Smith PB; Sun MJ; Murphy MD; Avant D; Mathis L; Rodriguez W; Califf RM; Li JS
Arch Pediatr Adolesc Med; 2009 Dec; 163(12):1080-6. PubMed ID: 19996043
[TBL] [Abstract][Full Text] [Related]
24. Alleged violations of subject protection rules led to an indefinite research shutdown.
Maloney DM
Hum Res Rep; 2000 Apr; 15(4):1-2. PubMed ID: 12201313
[No Abstract] [Full Text] [Related]
25. Guidelines for conducting responsible research.
Truluck CA; Johnston J
Radiol Technol; 2015; 86(5):584-9. PubMed ID: 25995410
[No Abstract] [Full Text] [Related]
26. Sex or Gender Reporting in Ophthalmology Clinical Trials Among US Food and Drug Administration Approvals, 1995 to 2022.
Xie JS; Kaur H; Tao B; Lee J; Solish D; Kohly R; Margolin E
JAMA Ophthalmol; 2024 Feb; 142(2):123-130. PubMed ID: 38236588
[TBL] [Abstract][Full Text] [Related]
27. Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals.
Downing NS; Shah ND; Neiman JH; Aminawung JA; Krumholz HM; Ross JS
Trials; 2016 Apr; 17():199. PubMed ID: 27079511
[TBL] [Abstract][Full Text] [Related]
28. The effect of scientific misconduct on the results of clinical trials: a Delphi survey.
Al-Marzouki S; Roberts I; Marshall T; Evans S
Contemp Clin Trials; 2005 Jun; 26(3):331-7. PubMed ID: 15911467
[TBL] [Abstract][Full Text] [Related]
29. A clinical trial primer: historical perspective and modern implementation.
Karsh LI
Urol Oncol; 2012; 30(4 Suppl):S28-32. PubMed ID: 22795078
[TBL] [Abstract][Full Text] [Related]
30. FDA audits of clinical studies: policy and procedure.
Lisook AB
J Clin Pharmacol; 1990 Apr; 30(4):296-302. PubMed ID: 2341577
[TBL] [Abstract][Full Text] [Related]
31. Clinical trials integrity: a CRO perspective.
Beach JE
Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
[TBL] [Abstract][Full Text] [Related]
32. Spin in RCTs of anxiety medication with a positive primary outcome: a comparison of concerns expressed by the US FDA and in the published literature.
Beijers L; Jeronimus BF; Turner EH; de Jonge P; Roest AM
BMJ Open; 2017 Mar; 7(3):e012886. PubMed ID: 28360236
[TBL] [Abstract][Full Text] [Related]
33. FDA sanctions for misconduct in clinical trials; results published as if nothing were amiss.
Prescrire Int; 2015 Dec; 24(166):307. PubMed ID: 26788584
[No Abstract] [Full Text] [Related]
34. Association of the FDA Amendment Act with trial registration, publication, and outcome reporting.
Phillips AT; Desai NR; Krumholz HM; Zou CX; Miller JE; Ross JS
Trials; 2017 Jul; 18(1):333. PubMed ID: 28720112
[TBL] [Abstract][Full Text] [Related]
35. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
Int J Evid Based Healthc; 2005 Jul; 3(6):147-67. PubMed ID: 21631747
[TBL] [Abstract][Full Text] [Related]
36. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
Hart B; Lundh A; Bero L
BMJ; 2012 Jan; 344():d7202. PubMed ID: 22214754
[TBL] [Abstract][Full Text] [Related]
37. Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016.
Moore TJ; Zhang H; Anderson G; Alexander GC
JAMA Intern Med; 2018 Nov; 178(11):1451-1457. PubMed ID: 30264133
[TBL] [Abstract][Full Text] [Related]
38. Scientific misconduct in investigational drug trials.
Shapiro MF; Charrow RP
N Engl J Med; 1985 Mar; 312(11):731-6. PubMed ID: 3974649
[No Abstract] [Full Text] [Related]
39. Publication of clinical trials supporting successful new drug applications: a literature analysis.
Lee K; Bacchetti P; Sim I
PLoS Med; 2008 Sep; 5(9):e191. PubMed ID: 18816163
[TBL] [Abstract][Full Text] [Related]
40. Development times, clinical testing, postmarket follow-up, and safety risks for the new drugs approved by the US food and drug administration: the class of 2008.
Moore TJ; Furberg CD
JAMA Intern Med; 2014 Jan; 174(1):90-5. PubMed ID: 24166236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
